David Middlemiss

Person

Bishop's Storford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Aniline derivatives, their preparation and their therapeutic applic...
- Patent number 9,624,159
- Issue date Apr 18, 2017
- Sanofi
- John Feutrill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aniline derivatives, their preparation and their therapeutic applic...
- Patent number 9,249,085
- Issue date Feb 2, 2016
- Fovea Pharmaceuticals
- John Feutrill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole derivatives as kinase inhibitors
- Patent number 8,883,820
- Issue date Nov 11, 2014
- Cellzome Ltd.
- Francis Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino triazoles as PI3K inhibitors
- Patent number 8,865,699
- Issue date Oct 21, 2014
- Cellzome Ltd.
- Nigel Ramsden
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds
- Patent number 8,389,530
- Issue date Mar 5, 2013
- Fovea Pharmaceuticals
- Caroline Leriche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,314,257
- Issue date Nov 20, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,198,314
- Issue date Jun 12, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,936
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,931
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptidase inhibitors
- Patent number 7,842,707
- Issue date Nov 30, 2010
- Nuada, LLC
- Susan Marie Royalty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of CRTH2-mediated diseases and conditions
- Patent number 7,582,672
- Issue date Sep 1, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives
- Patent number 5,843,966
- Issue date Dec 1, 1998
- Glaxo Group Limited
- Duncan Robert Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives
- Patent number 5,703,240
- Issue date Dec 30, 1997
- Glaxo Group Limited
- Duncan Robert Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzofuran derivatives
- Patent number 5,498,722
- Issue date Mar 12, 1996
- Glaxo Group
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
17 .beta.acyl 6 azaandrost-4,6 diazo-4-ene-3-ones
- Patent number 5,457,098
- Issue date Oct 10, 1995
- Glaxo Inc.
- Stephen V. Frye
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C-linked pyrazole derivatives
- Patent number 5,389,659
- Issue date Feb 14, 1995
- Glaxo Group Limited
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzofuran derivatives
- Patent number 5,374,646
- Issue date Dec 20, 1994
- Glaxo Group Limited
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzofuran derivatives
- Patent number 5,317,023
- Issue date May 31, 1994
- Glaxo Group Limited
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzofuran derivatives
- Patent number 5,310,927
- Issue date May 10, 1994
- Glaxo Group Limited
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic inhibitors of 5-.alpha.-testosterone reductase
- Patent number 5,302,589
- Issue date Apr 12, 1994
- Glaxo, Inc.
- Stephen V. Frye
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole containing benzofuran derivatives and pharmaceutical compo...
- Patent number 5,252,593
- Issue date Oct 12, 1993
- Glaxo Group Limited
- Barry C. Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethanolamine derivatives
- Patent number 5,039,697
- Issue date Aug 13, 1991
- Glaxo Group Limited
- Ian F. Skidmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethanolamine derivatives
- Patent number 5,032,609
- Issue date Jul 16, 1991
- Glaxo Group Limited
- Ian F. Skidmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amine derivatives
- Patent number 5,023,378
- Issue date Jun 11, 1991
- Glaxo Group Limited
- Michael D. Dowle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethanolamine derivatives
- Patent number 5,002,966
- Issue date Mar 26, 1991
- Glaxo Group Limited
- Ian F. Skidmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethanolamine derivatives
- Patent number 4,908,386
- Issue date Mar 13, 1990
- Glaxo Group Limited
- Harry Finch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANILINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLIC...
- Publication number 20160199330
- Publication date Jul 14, 2016
- SANOFI
- John FEUTRILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANILINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLIC...
- Publication number 20140350019
- Publication date Nov 27, 2014
- Fovea Pharmaceuticals
- John Feutrill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic compounds
- Publication number 20120041195
- Publication date Feb 16, 2012
- FOVEA PHARMACEUTICALS
- Caroline Leriche
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINE COMPOUNDS
- Publication number 20120004210
- Publication date Jan 5, 2012
- FOVEA Pharmaceuticals SA
- Caroline Leriche
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONAMIDES AS ZAP-70 INHIBITORS
- Publication number 20110098288
- Publication date Apr 28, 2011
- Jeremy Major
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFAMIDES AS ZAP-70 INHIBITORS
- Publication number 20110028405
- Publication date Feb 3, 2011
- Richard John Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO TRIAZOLES AS PI3K INHIBITORS
- Publication number 20110021497
- Publication date Jan 27, 2011
- Nigel Ramsden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Biaryl Amides
- Publication number 20100331410
- Publication date Dec 30, 2010
- ASTERAND UK LIMITED
- Robert Coleman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20100227800
- Publication date Sep 9, 2010
- CELLZOME LIMITED
- Francis Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
- Publication number 20100137300
- Publication date Jun 3, 2010
- George Hynd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRTH2 ANTAGONISTS
- Publication number 20100010034
- Publication date Jan 14, 2010
- George Hynd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE, BENZIMIDAZOLE, AND BENZOLACTAM BORONIC ACID COMPOUNDS, ANAL...
- Publication number 20090264384
- Publication date Oct 22, 2009
- Nuada, Inc.
- John R. Didsbury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for the identification of novel enzyme interacting compounds
- Publication number 20090238808
- Publication date Sep 24, 2009
- Gerard Drewes
- G01 - MEASURING TESTING
Information Patent Application
Indolizine Derivatives
- Publication number 20090163534
- Publication date Jun 25, 2009
- George Hynd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090023788
- Publication date Jan 22, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018138
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018139
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-Mediated diseases and conditions
- Publication number 20090018338
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Methods of Use Thereof
- Publication number 20090005344
- Publication date Jan 1, 2009
- NKUADA, LLC
- James F. Burns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and Methods of Use Thereof
- Publication number 20080319044
- Publication date Dec 25, 2008
- NUADA, LLC
- John R. Didsbury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indolizine Derivatives as Ligands of the Crth2 Receptor
- Publication number 20080306109
- Publication date Dec 11, 2008
- George Hynd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and Methods of Use Thereof
- Publication number 20080269204
- Publication date Oct 30, 2008
- Tatyana Dyakonov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Peptidase Inhibitors
- Publication number 20080234292
- Publication date Sep 25, 2008
- Susan Marie Royalty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having Crth2 Antagonist Activity
- Publication number 20070232681
- Publication date Oct 4, 2007
- Oxagen Limited
- David Middlemiss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20050119268
- Publication date Jun 2, 2005
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David Middlemiss

Person

Patents Grantslast 30 patents

Aniline derivatives, their preparation and their therapeutic applic...

Aniline derivatives, their preparation and their therapeutic applic...

Triazole derivatives as kinase inhibitors

Amino triazoles as PI3K inhibitors

Substituted quinazoline compounds

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Peptidase inhibitors

Compounds for the treatment of CRTH2-mediated diseases and conditions

Piperidine derivatives

Piperidine derivatives

Benzofuran derivatives

17 .beta.acyl 6 azaandrost-4,6 diazo-4-ene-3-ones

C-linked pyrazole derivatives

Benzofuran derivatives

Benzofuran derivatives

Benzofuran derivatives

Heterocyclic inhibitors of 5-.alpha.-testosterone reductase

Pyrazole containing benzofuran derivatives and pharmaceutical compo...

Ethanolamine derivatives

Ethanolamine derivatives

Amine derivatives

Ethanolamine derivatives

Ethanolamine derivatives

Patents Applicationslast 30 patents

ANILINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLIC...

ANILINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLIC...

Heterocyclic compounds

SUBSTITUTED QUINAZOLINE COMPOUNDS

SULFONAMIDES AS ZAP-70 INHIBITORS

SULFAMIDES AS ZAP-70 INHIBITORS

AMINO TRIAZOLES AS PI3K INHIBITORS

Biaryl Amides

TRIAZOLE DERIVATIVES AS KINASE INHIBITORS

Indolizine Acetic Acid Derivatives as CRTH2 Antagonists

CRTH2 ANTAGONISTS

INDOLE, BENZIMIDAZOLE, AND BENZOLACTAM BORONIC ACID COMPOUNDS, ANAL...

Process for the identification of novel enzyme interacting compounds

Indolizine Derivatives

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-Mediated diseases and conditions

Compounds and Methods of Use Thereof

Compounds and Methods of Use Thereof

Indolizine Derivatives as Ligands of the Crth2 Receptor

Compounds and Methods of Use Thereof

Peptidase Inhibitors

Compounds Having Crth2 Antagonist Activity

Treatment of CRTH2-mediated diseases and conditions